IRIS Accounts Production v24.3.2.46 11156043 director 1.5.23 30.4.24 30.4.24 0 0 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh111560432023-04-30111560432024-04-30111560432023-05-012024-04-30111560432022-04-30111560432022-05-012023-04-30111560432023-04-3011156043ns15:EnglandWales2023-05-012024-04-3011156043ns14:PoundSterling2023-05-012024-04-3011156043ns10:Director12023-05-012024-04-3011156043ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3011156043ns10:SmallEntities2023-05-012024-04-3011156043ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3011156043ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3011156043ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3011156043ns10:FullAccounts2023-05-012024-04-3011156043ns10:OrdinaryShareClass12023-05-012024-04-3011156043ns10:RegisteredOffice2023-05-012024-04-3011156043ns5:CurrentFinancialInstruments2024-04-3011156043ns5:CurrentFinancialInstruments2023-04-3011156043ns5:Non-currentFinancialInstruments2024-04-3011156043ns5:Non-currentFinancialInstruments2023-04-3011156043ns5:ShareCapital2024-04-3011156043ns5:ShareCapital2023-04-3011156043ns5:FurtherSpecificReserve3ComponentTotalEquity2024-04-3011156043ns5:FurtherSpecificReserve3ComponentTotalEquity2023-04-3011156043ns5:RetainedEarningsAccumulatedLosses2024-04-3011156043ns5:RetainedEarningsAccumulatedLosses2023-04-3011156043ns5:ComputerEquipment2023-05-012024-04-3011156043ns5:ComputerEquipment2023-04-3011156043ns5:ComputerEquipment2024-04-3011156043ns5:ComputerEquipment2023-04-3011156043ns5:CostValuation2023-04-3011156043ns5:RevaluationsIncreaseDecreaseInInvestments2024-04-3011156043ns5:CostValuation2024-04-3011156043ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3011156043ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-3011156043ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-04-3011156043ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2023-04-3011156043ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-04-3011156043ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-04-3011156043ns5:DeferredTaxation2023-04-3011156043ns5:DeferredTaxation2023-05-012024-04-3011156043ns5:DeferredTaxation2024-04-3011156043ns10:OrdinaryShareClass12024-04-3011156043ns5:FurtherSpecificReserve3ComponentTotalEquity2023-04-30111560431ns10:Director12023-04-30111560431ns10:Director12022-04-30111560431ns10:Director12023-05-012024-04-30111560431ns10:Director12022-05-012023-04-30111560431ns10:Director12024-04-30111560431ns10:Director12023-04-30
REGISTERED NUMBER: 11156043 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

30 APRIL 2024

FOR

ABHB (SUSSEX) LIMITED

ABHB (SUSSEX) LIMITED (REGISTERED NUMBER: 11156043)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


ABHB (SUSSEX) LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 APRIL 2024







DIRECTOR: A Bansel FCA





REGISTERED OFFICE: Pharmacy Chambers
High Street
Wadhurst
East Sussex
TN5 6AP





REGISTERED NUMBER: 11156043 (England and Wales)





ACCOUNTANTS: Honey Barrett Limited
Chartered Accountants
Pharmacy Chambers
High Street
Wadhurst
East Sussex
TN5 6AP

ABHB (SUSSEX) LIMITED (REGISTERED NUMBER: 11156043)

BALANCE SHEET
30 APRIL 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 829 624
Investments 6 515,783 592,224
516,612 592,848

CURRENT ASSETS
Debtors 7 6,838 9,421
Cash at bank 35,086 24,996
41,924 34,417
CREDITORS
Amounts falling due within one year 8 22,344 25,940
NET CURRENT ASSETS 19,580 8,477
TOTAL ASSETS LESS CURRENT
LIABILITIES

536,192

601,325

CREDITORS
Amounts falling due after more than one
year

9

(151,782

)

(169,440

)

PROVISIONS FOR LIABILITIES 10 (43,641 ) (64,277 )
NET ASSETS 340,769 367,608

ABHB (SUSSEX) LIMITED (REGISTERED NUMBER: 11156043)

BALANCE SHEET - continued
30 APRIL 2024

2024 2023
Notes £    £    £    £   
CAPITAL AND RESERVES
Called up share capital 11 100 100
Fair value reserve 12 136,949 194,280
Retained earnings 203,720 173,228
SHAREHOLDERS' FUNDS 340,769 367,608

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered.

The financial statements were approved by the director and authorised for issue on 30 January 2025 and were signed by:





A Bansel FCA - Director


ABHB (SUSSEX) LIMITED (REGISTERED NUMBER: 11156043)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024


1. STATUTORY INFORMATION

Abhb (Sussex) Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Equipment - straight line over 3 years

All fixed assets are originally recorded at cost.

Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the asset of the entity after deducting all of its financial liabilities.

When the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Financial costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.


ABHB (SUSSEX) LIMITED (REGISTERED NUMBER: 11156043)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024


3. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Unlisted investments
Unlisted investments have been measured at cost less impairment.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

ABHB (SUSSEX) LIMITED (REGISTERED NUMBER: 11156043)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024


5. TANGIBLE FIXED ASSETS
Equipment
£   
COST
At 1 May 2023 1,623
Additions 482
At 30 April 2024 2,105
DEPRECIATION
At 1 May 2023 999
Charge for year 277
At 30 April 2024 1,276
NET BOOK VALUE
At 30 April 2024 829
At 30 April 2023 624

6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST OR VALUATION
At 1 May 2023 592,224
Revaluations (76,441 )
At 30 April 2024 515,783
NET BOOK VALUE
At 30 April 2024 515,783
At 30 April 2023 592,224

ABHB (SUSSEX) LIMITED (REGISTERED NUMBER: 11156043)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024


6. FIXED ASSET INVESTMENTS - continued

Cost or valuation at 30 April 2024 is represented by:

Other
investments
£   
Valuation in 2018 324,285
Valuation in 2021 1,000
Valuation in 2022 7,899
Valuation in 2023 259,040
Valuation in 2024 (76,441 )
515,783

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors - 4,750
Director's current account 6,338 1,671
Prepayments and accrued income 500 3,000
6,838 9,421

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 661 594
Other loans 21,487 24,715
Corporation tax (95 ) 95
Accruals and deferred income 291 536
22,344 25,940

ABHB (SUSSEX) LIMITED (REGISTERED NUMBER: 11156043)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024


9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans - 1-2 years 639 1,189
Bank loans - 2-5 years - 156
Other loans - 1-2 years 23,396 26,634
Other loans - 2-5 years 83,341 92,961
Other loans more 5yrs instal 44,406 48,500
151,782 169,440

Amounts falling due in more than five years:

Repayable by instalments
Other loans more 5yrs instal 44,406 48,500

10. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax 43,641 64,277

Deferred
tax
£   
Balance at 1 May 2023 64,277
Provided during year (20,636 )
Balance at 30 April 2024 43,641

11. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary £1 100 100

ABHB (SUSSEX) LIMITED (REGISTERED NUMBER: 11156043)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024


12. RESERVES
Fair
value
reserve
£   
At 1 May 2023 194,280
Transfer (57,331 )

At 30 April 2024 136,949

13. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 April 2024 and 30 April 2023:

2024 2023
£    £   
A Bansel FCA
Balance outstanding at start of year 1,671 (21,088 )
Amounts advanced 12,958 22,759
Amounts repaid (8,291 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 6,338 1,671

14. RELATED PARTY DISCLOSURES

The company paid an interest charge of £214 (2023: £1,380) to the Director at 7% on the Director's loan account.